Although cancer diagnosis during pregnancy is a rare phenomenon, it is still a very important topic to be discussed and investigated. It represents a biological paradox and is considered as a dramatic event not only in a woman's life but also in her partner and her family. It implicates medical, psychological, ethical, social, and religious issues.

To diagnose and to treat a pregnant mother with cancer is an exceptionally difficult problem because it involves two persons. It involves the mother herself as well as the fetus. Therefore, both obstetricians and oncologists should provide optimal and safe diagnostic and therapeutic management. They should try to benefit mother's life by treating curable malignant diseases and by retaining her reproductive system intact for future gestations. At the same time however, they should protect fetus and newborn from harmful effects of cancer diagnostic procedures and of various therapeutic modalities.

It is very essential to know that in view of today's trend for delaying pregnancy into the later reproductive years, we might expect to see more cancer cases complicating pregnancies.

Despite the fact that cancer during pregnancy remains an uncommon coexistence (almost one cancer every 1000 pregnancies) breast cancer, cervical cancer, melanoma and hematological malignancies are the most commonly diagnosed tumors.

In this special issue we decided to deal with the most rare gestational cancers and to present for first time in the literature accumulating and updated data on thyroid, renal, lung, blood cancers, bone and soft tissue sarcomas.
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